Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Franklin Ning"'
Autor:
Brittney S. Harrington, Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lidia F. Hernandez, Donna Butcher, Elijah F. Edmondson, Nadia Traficante, Joy Hendley, Australian Ovarian Cancer Study, Madeline Gough, Rebecca Rogers, Rohan Lourie, Jyoti Shetty, Bao Tran, Fathi Elloumi, Abdalla Abdelmaksoud, Madhu Lal Nag, Krystyna Mazan-Mamczarz, Carrie D. House, John D. Hooper, Christina M. Annunziata
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-22 (2023)
Abstract Background Epithelial ovarian cancer (EOC) is a global health burden, with the poorest five-year survival rate of the gynecological malignancies due to diagnosis at advanced stage and high recurrence rate. Recurrence in EOC is driven by the
Externí odkaz:
https://doaj.org/article/e245f4306b05418da579333a9dcc9d93
Autor:
Yusuke Shibuya, Kei Kudo, Kristen P. Zeligs, David Anderson, Lidia Hernandez, Franklin Ning, Christopher B. Cole, Maria Fergusson, Noemi Kedei, John Lyons, Jason Taylor, Soumya Korrapati, Christina M. Annunziata
Publikováno v:
Cancers, Vol 15, Iss 4, p 1315 (2023)
The overexpression of inhibitor of apoptosis (IAP) proteins is strongly related to poor survival of women with ovarian cancer. Recurrent ovarian cancers resist apoptosis due to the dysregulation of IAP proteins. Mechanistically, Second Mitochondrial
Externí odkaz:
https://doaj.org/article/6c87cba16db0410abe4a35444f5e01ec
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Ovarian cancer is the leading cause of death among gynecological neoplasms, with an estimated 14,000 deaths in 2019. First-line treatment options center around a taxane and platinum-based chemotherapy regimen. However, many patients often have recurr
Externí odkaz:
https://doaj.org/article/94d777549c884e568b3be3d1407c9408
Autor:
Christina M. Annunziata, Christopher B. Cole, Kathryn C. Zoon, Ana T. Nunes, Lindsey B. Rosen, Steven M. Holland, Soumya Korrapati, Chauha Pham, JoLynn Procter, Sandhya Panch, Naoza Collins-Johnson, David F. Stroncek, Steven L. Highfill, Yovanni Casablanca, Andrew Blakely, Leslie Smith, Erin N. Villanueva, Miroslava Pavelova, Alexandra Zimmer, Stanley Lipkowitz, Jung-min Lee, Nicole Houston, Ann McCoy, Irene Ekwede, Kathryn Trewhitt, Timothy G. Myers, Anna Duemler, Franklin Ning, Daniel S. Green
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2feab5077d48472041562350e1b5e877
https://doi.org/10.1158/1078-0432.22488489.v1
https://doi.org/10.1158/1078-0432.22488489.v1
Autor:
Christina M. Annunziata, Christopher B. Cole, Kathryn C. Zoon, Ana T. Nunes, Lindsey B. Rosen, Steven M. Holland, Soumya Korrapati, Chauha Pham, JoLynn Procter, Sandhya Panch, Naoza Collins-Johnson, David F. Stroncek, Steven L. Highfill, Yovanni Casablanca, Andrew Blakely, Leslie Smith, Erin N. Villanueva, Miroslava Pavelova, Alexandra Zimmer, Stanley Lipkowitz, Jung-min Lee, Nicole Houston, Ann McCoy, Irene Ekwede, Kathryn Trewhitt, Timothy G. Myers, Anna Duemler, Franklin Ning, Daniel S. Green
Purpose:Ovarian cancer is the most lethal gynecologic cancer and intrinsically resistant to checkpoint immunotherapies. We sought to augment innate immunity, building on previous work with IFNs and monocytes.Patients and Methods:Preclinical experimen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5d6f3d1a19ff96c8ac9b3ce92c531b
https://doi.org/10.1158/1078-0432.c.6532740.v1
https://doi.org/10.1158/1078-0432.c.6532740.v1
Publikováno v:
Regular and Young Investigator Award Abstracts.
Epithelial ovarian cancer (EOC) is a global health burden, with the poorest five-year survival rate of the gynecological malignancies due to diagnosis at advanced stage and high recurrence rate. Recurrence in EOC is driven by the survival of chemores
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4773347c7c68bb321e449805b697db43
https://doi.org/10.1101/2022.10.07.509566
https://doi.org/10.1101/2022.10.07.509566
Autor:
Daniel S. Green, Franklin Ning, Anna Duemler, Timothy G. Myers, Kathryn Trewhitt, Irene Ekwede, Ann McCoy, Nicole Houston, Jung-min Lee, Stanley Lipkowitz, Alexandra Zimmer, Miroslava Pavelova, Erin N. Villanueva, Leslie Smith, Andrew Blakely, Yovanni Casablanca, Steven L. Highfill, David F. Stroncek, Naoza Collins-Johnson, Sandhya Panch, JoLynn Procter, Chauha Pham, Soumya Korrapati, Steven M. Holland, Lindsey B. Rosen, Ana T. Nunes, Kathryn C. Zoon, Christopher B. Cole, Christina M. Annunziata
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose: Ovarian cancer is the most lethal gynecologic cancer and intrinsically resistant to checkpoint immunotherapies. We sought to augment innate immunity, building on previous work with IFNs and monocytes. Patients and Methods: Preclinical experi
Autor:
Christopher B. Cole, Daniel S. Green, Franklin Ning, Kathryn Zoon, Lindsey B. Rosen, Steven M. Holland, Christina M. Annunziata
Publikováno v:
Cancer Research. 82:3577-3577
Background: Ovarian cancer is the most lethal gynecologic cancer and is intrinsically resistant to immunotherapies. Previous work has demonstrated superior response rates with intraperitoneally (IP) directed therapies, providing the rationale for IP
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
Ovarian cancer is the leading cause of death among gynecological neoplasms, with an estimated 14,000 deaths in 2019. First-line treatment options center around a taxane and platinum-based chemotherapy regimen. However, many patients often have recurr